ArticleFrontiers in medicine2026
Spinal metastases in geriatric patients: a retrospective single-center comparison of mortality and surgical outcomes following neurosurgical treatment.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinal metastases (SM) are increasingly common. In an aging population, this trend raises concerns regarding the safety and efficacy of surgical treatment (ST) in geriatric patients. This study aimed to compare postoperative outcomes, complications, recurrence, readmission, and mortality between geriatric and non-geriatric patients undergoing ST for SM. Methods: Our retrospective cohort study included 277 patients who underwent ST for SM between 2012 and 2024. Patients were stratified into non-geriatric (< 70 years, Results: Geriatric patients had a higher preoperative comorbidity burden and lower functional status. However, early outcomes, such as postoperative complications, readmission rates, and local tumor recurrence, did not differ significantly between age groups. Median overall survival was 12.0 months in patients < 70 years and 10.5 months in patients ≥ 70 years ( Conclusion: Our data demonstrates that geriatric patients undergoing ST for SM did not experience worse early postoperative outcomes. Careful patient selection based on functional status and perioperative risk factors remains essential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.